Procter & Gamble Health Ltd Stock Analysis

BSE: 500126 | NSE: PGHL | Pharmaceuticals & Drugs | Mid Cap

BSE Share Price Jan 21, 18:01
5086.10 18.55 (0.37%)

DeciZen - Make an Informed Decision on Procter&Gamble Healt

Overall Rating

1. Quality

2. Valuation

Overvalued
P/E P/S EV/EBITDA

3. Price Trend

FAQ's

1. Is Procter & Gamble Health Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Procter & Gamble Health Ltd is a good quality company.

2. Is Procter & Gamble Health Ltd undervalued or overvalued?

The key valuation ratios of Procter & Gamble Health Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Procter & Gamble Health Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Procter & Gamble Health Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Procter&Gamble Healt:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Procter & Gamble Health Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide
Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21TTM
ROCE % 16.9%17.5%11%7.9%9.2%12.3%11.5%73.3%20.8%22.1%-
Value Creation Index 0.20.3-0.2-0.4-0.3-0.1-0.24.20.50.6-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 5906877988679409936981,2889041,0091,018
YoY Gr. Rt. %-16.6%16.1%8.7%8.3%5.7%-29.7%84.5%-29.8%11.6%-
Adj EPS 38.447.133.425.531.746.648.6502.1102.2106.7104.2
YoY Gr. Rt. %-22.6%-29.1%-23.4%24.2%47.1%4.2%933.8%-79.6%4.4%-
BVPS (₹) 247291.4315.1333.9356.4399.9441.7927.8363.2421.6455
Adj Net Profit 63.878.155.442.452.677.480.6833170177173
Cash Flow from Ops. 18.854.30.5583.510753.7-130157247-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 6.2%1.4%13.1%11.6%
Adj EPS 12%27.5%30%4.4%
BVPS 6.13.4-1.516.1
Share Price 23.5% 40% 15.4% -28.1%

Key Financial Parameters

Performance Ratio Colour Code Guide
Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21TTM
Return on Equity % 16.917.5117.99.212.311.573.320.82223.8
Op. Profit Mgn % 12.315.49.76.8911.710.116.323.424.424.2
Net Profit Mgn % 10.811.46.94.95.67.811.664.718.817.617
Debt to Equity 0000000000-
Working Cap Days 2733652352483813675033213464910
Cash Conv. Cycle 57717485826688151260

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 13.05%

Net Profit is growing at healthy rate in last 3 years 29.99%

Sales growth is good in last 4 quarters at 10.69%

Return on Equity has declined versus last 3 years average to 23.80%

Latest Financials - Procter & Gamble Health Ltd.

Standalone Consolidated
TTM EPS (₹) 104.2 -
TTM Sales (₹ Cr.) 1,018 -
BVPS (₹.) 455 -
Reserves (₹ Cr.) 739 -
P/BV 11.18 -
PE 48.83 -
From the Market
52 Week Low / High (₹) 4910.00 / 7499.95
All Time Low / High (₹) 114.00 / 7499.95
Market Cap (₹ Cr.) 8,443
Equity (₹ Cr.) 16.6
Face Value (₹) 10
Industry PE 39.1

Management X-Ray of Procter&Gamble Healt :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967.  It was also the first Merck Group Company to go public in the year 1981.  Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.

On December 1st, 2018, P&G successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfilment of other customary closing conditions. Procter & Gamble Overseas India B.V. now holds 51.81% of the share capital in Merck Limited, while the remaining 48.19% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.

Currently, Procter & Gamble Health Limited (formerly Merck Limited) is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life. With a strong portfolio of brands backed by science and trusted by doctors, pharmacists and consumers, Procter & Gamble Health Limited combines the best of P&G and Legacy Merck’s Consumer Health capabilities and cultures. Together we are working towards leveraging our combined expertise to develop categories and brands that meet today’s needs and tomorrow’s opportunities.

Situated at Usgaon, Goa, the company’s Manufacturing Site has grown from a small Vitamin E producing unit to a big composite plant manufacturing pharma and chemical products.

Business area of the company

Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Brands of the company

  • Neurobion
  • Evion
  • Seven Seas
  • Nasivion
  • Polybion
  • Livogen

Awards and achievements

  • 2015-16: Merck Goa plant was awarded 1st prize in safety called “Gomant Sarvochcha Suraksha Puraskar”. This is consecutive 2nd time Merck Goa plant bagged 1st prize in safety. Prior to that Merck Goa plant bagged 2nd prize in safety “Gomant Uchcha Suraksha Puraskar” for two consecutive years.
  • 2016-17: Consumer activation done for Neurobion under ‘True Heroes’ campaign won laurels at the Global level to receive President’s Award in 2017.
  • 2017-18: Nasivion continued to be the Doctors’ trusted No. 1 Nasal Decongestant.
  • 2019-20: Neurobion bagged three awards viz. Nicholas Hall Marketing Excellence Award; CIMS Trusted Brand of the Year; and ABP News Brand Excellence Award.
Read More Read Less